{"id":27920,"date":"2024-04-19T14:08:38","date_gmt":"2024-04-19T12:08:38","guid":{"rendered":"https:\/\/vilkaviskiovsb.lt\/?p=27920"},"modified":"2024-04-19T14:08:38","modified_gmt":"2024-04-19T12:08:38","slug":"pasikeite-kosmetikos-gaminiu-reglamentavimas","status":"publish","type":"post","link":"https:\/\/vilkaviskiovsb.lt\/lt_lt\/2024\/04\/19\/pasikeite-kosmetikos-gaminiu-reglamentavimas\/","title":{"rendered":"Pasikeit\u0117 kosmetikos gamini\u0173 reglamentavimas"},"content":{"rendered":"<div class=\"info-block__wrap clearfix\">\n<p><strong>2024 m. kovo 14 d. Europos Komisija pri\u0117m\u0117 Komisijos reglament\u0105 (ES) 2024\/858, kuriuo d\u0117l nanomed\u017eiag\u0173 (13) naudojimo kosmetikos gaminiuose i\u0161 dalies kei\u010diamas Europos Parlamento ir Tarybos reglamentas (EB) Nr. 1223\/2009 d\u0117l kosmetikos gamini\u0173.<\/strong><\/p>\n<p>\u0160iuo reglamentu kosmetikos gaminiuose draud\u017eiama naudoti nanomed\u017eiagas: <strong>Styrene \/ Acrylates copolymer, Sodium Styrene \/ Acrylates copolymer, Copper, Colloidal Copper, Gold, Colloidal Gold, Gold Thioethylamino Hyaluronic Acid, Acetyl heptapeptide-9 Colloidal gold, Platinum, Colloidal Platinum, Acetyl tetrapeptide-17 Colloidal Platinum <\/strong>ir<strong> Colloidal Silver<\/strong>,nes jos yra \u012ftrauktos \u012f Reglamento (EB) Nr. 1223\/2009 II pried\u0105 <em>(Kosmetikos gaminiuose draud\u017eiam\u0173 med\u017eiag\u0173 s\u0105ra\u0161as). Nanomed\u017eiagos\u00a0<\/em><strong>Hydroxyapatite<\/strong><strong>\u00a0 <\/strong>naudojimas kosmetikos gaminuose yra apribojamas, nes ji yra \u012ftraukta \u012f Reglamento (EB) Nr. 1223\/2009 III pried\u0105 (<em>Med\u017eiag\u0173, leid\u017eiam\u0173 naudoti kosmetikos gamini\u0173 gamybai tik laikantis nustatyt\u0173 apribojim\u0173, s\u0105ra\u0161as)<\/em><em>. Nanomed\u017eiaga <\/em><em>\u00a0<\/em><strong>Hydroxyapatite <\/strong>gali b\u016bti naudojama dant\u0173 pastoje (iki 10 %) ir burnos skalavimo skystyje (iki 0,465 %).<\/p>\n<p><a name=\"_Hlk164346785\"><\/a>Daugiau informacijos adresu <a href=\"https:\/\/nvsc.lrv.lt\/lt\/veiklos-sritys\/kosmetikos-reglamento-igyvendinimo-pagalba\/teises-aktu-naujienos\/\">https:\/\/nvsc.lrv.lt\/lt\/veiklos-sritys\/kosmetikos-reglamento-igyvendinimo-pagalba\/teises-aktu-naujienos\/<\/a><\/p>\n<p>&nbsp;<\/p>\n<p class=\"Default\"><strong>2024 m. baland\u017eio 3 d. Europos Komisija pri\u0117m\u0117 Komisijos reglament\u0105 (ES) 2024\/996, kuriuo <\/strong><strong>d\u0117l vitamino A, alfa arbutino (\u201eAlpha-Arbutin\u201c), arbutino (\u201eArbutin\u201c) ir tam tikr\u0173 endokrinin\u0119 sistem\u0105 galin\u010di\u0173 ardyti med\u017eiag\u0173 naudojimo kosmetikos gaminiuose i\u0161 dalies kei\u010diamas Europos Parlamento ir Tarybos reglamentas (EB) Nr. 1223\/2009.<\/strong><\/p>\n<p>\u0160iuo reglamentu kosmetikos gaminiuose draud\u017eiama naudoti chemin\u0119 med\u017eiag\u0105 <strong>4-Methylbenzylidene Camphor<\/strong>, nes ji yra\u00a0 i\u0161braukta i\u0161 VI priedo <em>(UV filtr\u0173, kuriuos galima naudoti kosmetikos gaminiuose, s\u0105ra\u0161as) <\/em><em>ir <\/em>\u012ftraukta \u012f Reglamento (EB) Nr. 1223\/2009 II pried\u0105 <em>(Kosmetikos gaminiuose draud\u017eiam\u0173 med\u017eiag\u0173 s\u0105ra\u0161as)<\/em><em>.<\/em> Taip pat \u0161iuo reglamentu kosmetikos gaminiuose \u00a0apribojamas \u00a0toki\u0173 \u00a0med\u017eiag\u0173 kaip <strong>Genistein, Daidzein, Kojic Acid, Retinol, Retinyl Acetate, Retinyl Palmitate, Alpha-Arbutin, \u00a0Arbutin<\/strong> naudojimas, nes jos yra \u012ftrauktos \u012f Reglamento (EB) Nr. 1223\/2009 III pried\u0105 (<em>Med\u017eiag\u0173, leid\u017eiam\u0173 naudoti kosmetikos gamini\u0173 gamybai tik laikantis nustatyt\u0173 apribojim\u0173, s\u0105ra\u0161as)<\/em><em>. Dar reglamentu yra pakeisti <\/em>Reglamento (EB) Nr. 1223\/2009 V priedo <em>(Konservant\u0173, leid\u017eiam\u0173 naudoti kosmetikos gaminiuose, s\u0105ra\u0161as) <\/em>23 (<strong>Triclocarban<\/strong>) ir 25 (<strong>Triclosan<\/strong>) \u012fra\u0161ai.<\/p>\n<p>Daugiau informacijos adresu <a href=\"https:\/\/nvsc.lrv.lt\/lt\/veiklos-sritys\/kosmetikos-reglamento-igyvendinimo-pagalba\/teises-aktu-naujienos\/\">https:\/\/nvsc.lrv.lt\/lt\/veiklos-sritys\/kosmetikos-reglamento-igyvendinimo-pagalba\/teises-aktu-naujienos\/<\/a><\/p>\n<\/div>\n<div class=\"info-block__wrap clearfix\">\n<p>Atnaujinimo data: 2024-04-19<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>2024 m. kovo 14 d. Europos Komisija pri\u0117m\u0117 Komisijos reglament\u0105 (ES) 2024\/858, kuriuo d\u0117l nanomed\u017eiag\u0173 (13) naudojimo kosmetikos gaminiuose i\u0161 dalies kei\u010diamas Europos Parlamento ir Tarybos reglamentas (EB) Nr. 1223\/2009 d\u0117l kosmetikos gamini\u0173. \u0160iuo reglamentu kosmetikos gaminiuose draud\u017eiama naudoti nanomed\u017eiagas: Styrene \/ Acrylates copolymer, Sodium Styrene \/ Acrylates copolymer, Copper, Colloidal Copper, Gold, Colloidal Gold,&hellip;<\/p>\n","protected":false},"author":3,"featured_media":27921,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_feature_clip_id":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2},"jetpack_post_was_ever_published":false},"categories":[6],"tags":[],"class_list":["post-27920","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-naujienos","category-6","description-off"],"jetpack_publicize_connections":[],"jetpack_sharing_enabled":true,"jetpack_shortlink":"https:\/\/wp.me\/p7kWFe-7gk","jetpack_featured_media_url":"https:\/\/vilkaviskiovsb.lt\/wp-content\/uploads\/2024\/04\/El20WYOjs53h.jpg","post_mailing_queue_ids":[],"_links":{"self":[{"href":"https:\/\/vilkaviskiovsb.lt\/lt_lt\/wp-json\/wp\/v2\/posts\/27920","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/vilkaviskiovsb.lt\/lt_lt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/vilkaviskiovsb.lt\/lt_lt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/vilkaviskiovsb.lt\/lt_lt\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/vilkaviskiovsb.lt\/lt_lt\/wp-json\/wp\/v2\/comments?post=27920"}],"version-history":[{"count":1,"href":"https:\/\/vilkaviskiovsb.lt\/lt_lt\/wp-json\/wp\/v2\/posts\/27920\/revisions"}],"predecessor-version":[{"id":27922,"href":"https:\/\/vilkaviskiovsb.lt\/lt_lt\/wp-json\/wp\/v2\/posts\/27920\/revisions\/27922"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/vilkaviskiovsb.lt\/lt_lt\/wp-json\/wp\/v2\/media\/27921"}],"wp:attachment":[{"href":"https:\/\/vilkaviskiovsb.lt\/lt_lt\/wp-json\/wp\/v2\/media?parent=27920"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/vilkaviskiovsb.lt\/lt_lt\/wp-json\/wp\/v2\/categories?post=27920"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/vilkaviskiovsb.lt\/lt_lt\/wp-json\/wp\/v2\/tags?post=27920"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}